HER2 Support Group Forums - View Single Post - Immune-modified ex vivo platform can measure treatment response of ovarian cancer

News · 03-11-2021, 11:35 PM

KIYATEC, Inc researchers demonstrated that their immune-modified ex vivo platform can measure treatment response through direct interaction between a patient's cancer and infiltrating immune cells, and immuno-oncology agents.

More...

03-11-2021, 11:35 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,987	Immune-modified ex vivo platform can measure treatment response of ovarian cancer KIYATEC, Inc researchers demonstrated that their immune-modified ex vivo platform can measure treatment response through direct interaction between a patient's cancer and infiltrating immune cells, and immuno-oncology agents. More...